Latest News about KURA
Recent news which mentions KURA
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 15, 2022
February 15, 2022
From Benzinga
The Daily Biotech Pulse: Kura Lifts Clinical Hold On Blood Cancer Trial, Intuitive Surgical Earnings, Sorrento's Omicron Antibody Treatment Effective
January 21, 2022
From Benzinga
FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
January 21, 2022
Tickers
KURA
From Benzinga
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
December 06, 2021
From Benzinga
68 Biggest Movers From Wednesday
November 26, 2021
From Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
November 24, 2021
From Benzinga
See Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
November 24, 2021
Tickers
KURA
From Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
November 24, 2021
From Benzinga
The Daily Biotech Pulse: Kura's Blood Cancer Drug Study Gets Partial Clinical Hold, Takeda FDA Nod, Puma Breast Cancer Treatment Gets Patent Extension
November 24, 2021
From Benzinga
Kura Oncology, inc (KURA) Q3 2021 Earnings Call Transcript
November 05, 2021
Tickers
KURA
From Motley Fool
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
From Benzinga
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
August 20, 2021
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Monday
August 16, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Friday
August 13, 2021
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Wednesday
August 11, 2021
From Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
From Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.